Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats

Authors: Woo-Young Jeon, Ohn Soon Kim, Chang-Seob Seo, Seong Eun Jin, Jung-Ae Kim, Hyeun-Kyoo Shin, Yong-ung Kim, Mee-Young Lee

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Benign prostatic hyperplasia (BPH) is non-cancerous condition of enlargement of the prostate, a common occurrence in older men. The immature fruits of Poncirus trifoliata (L.) Rafinesque (Rutaceae), Ponciri Fructus are widely used in traditional oriental medicine for the therapy of various diseases. However, little is known about the mechanism underlying the pathogenesis of BPH. In the present study, we investigated the protective effects of a Ponciri Fructus extract (PFE) on the development of BPH in a in a rat model of BPH induced by testosterone propionate (TP).

Methods

Male Sprague Dawley rats were used as a model of BPH after its induction by daily subcutaneous injections of TP/corn oil, for a period of four weeks. PFE was administrated daily 1 h before TP/corn oil injection by oral gavage at a dose level of 200 mg/kg during the 4 weeks of TP/corn oil injections. All rats were sacrificed at the end of the experiment, we measured the relative prostate weight, the levels of testosterone and dihydrotestosterone (DHT), histological changes, activities of antioxidant enzymes (catalase, glutathione peroxidase, glutathione reductase, and superoxide dismutase), and expression of proliferating cell nuclear antigen (PCNA). In addition, we also measured the inhibition (%) of 5α-reductase in the prostatic tissue.

Results

Our findings indicate that PFE significantly inhibited the development of BPH; decreased the relative prostate weight, the level of testosterone and DHT in serum and prostatic tissue, prostatic hyperplasia, expression of PCNA, and increased the antioxidant enzymes. Moreover, PFE showed a weak inhibitory activity on 5α-reductase.

Conclusions

These results suggest that PFE may be used as a therapeutic agent for BPH via antiproliferative and antioxidant effects.
Literature
3.
go back to reference Lucia MS, Lambert JR. Growth factors in benign prostatic hyperplasia: basic science implications. Curr Urol Rep. 2008;9:272–8.CrossRefPubMed Lucia MS, Lambert JR. Growth factors in benign prostatic hyperplasia: basic science implications. Curr Urol Rep. 2008;9:272–8.CrossRefPubMed
4.
go back to reference Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol. 2004;172:1399–403.CrossRefPubMed Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol. 2004;172:1399–403.CrossRefPubMed
5.
go back to reference Carson C 3rd, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003;61:2–7.CrossRefPubMed Carson C 3rd, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003;61:2–7.CrossRefPubMed
8.
go back to reference Yang X, Yuan L, Xiong C, Yin C, Ruan J. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative. J Ethnopharmacol. 2014;157:105–13. doi:10.1016/j.jep.2014.09.025.CrossRefPubMed Yang X, Yuan L, Xiong C, Yin C, Ruan J. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative. J Ethnopharmacol. 2014;157:105–13. doi:10.​1016/​j.​jep.​2014.​09.​025.CrossRefPubMed
9.
go back to reference KAPE: Handbook of the Korea Pharmacopoeia. 9th ed. Shinilbooks. Korea: Seoul; 2008. p. 1176–7. KAPE: Handbook of the Korea Pharmacopoeia. 9th ed. Shinilbooks. Korea: Seoul; 2008. p. 1176–7.
11.
go back to reference Lee JH, Lee SH, Kim YS, Jeong CS. Protective effects of neohesperidin and poncirin isolated from the fruits of Poncirus trifoliata on potential gastric disease. Phytother Res. 2009;23:1748–53. doi:10.1002/ptr.2840.CrossRefPubMed Lee JH, Lee SH, Kim YS, Jeong CS. Protective effects of neohesperidin and poncirin isolated from the fruits of Poncirus trifoliata on potential gastric disease. Phytother Res. 2009;23:1748–53. doi:10.​1002/​ptr.​2840.CrossRefPubMed
12.
go back to reference Seo CS, Jeong SJ, Yoo SR, Lee NR, Shin HK: Quantitative Analysis and In vitro Anti-inflammatory Effects of Gallic Acid, Ellagic Acid, and Quercetin from Radix Sanguisorbae. Pharmacogn Mag 2016, 12:104–108. doi:10.4103/0973-1296.177908 Seo CS, Jeong SJ, Yoo SR, Lee NR, Shin HK: Quantitative Analysis and In vitro Anti-inflammatory Effects of Gallic Acid, Ellagic Acid, and Quercetin from Radix Sanguisorbae. Pharmacogn Mag 2016, 12:104–108. doi:10.​4103/​0973-1296.​177908
16.
go back to reference Lim HS, Yeji K, Seo CS, Yoo SR, Jin SE, Shin HK, Jeong SJ: Chungsimyeonja-eum inhibits inflammatory responses in RAW 264.7 macrophages and HaCaT keratinocytes. BMC Complement Altern Med 2015, 15:371. doi: 10.1186/s12906-015-0902-2. Lim HS, Yeji K, Seo CS, Yoo SR, Jin SE, Shin HK, Jeong SJ: Chungsimyeonja-eum inhibits inflammatory responses in RAW 264.7 macrophages and HaCaT keratinocytes. BMC Complement Altern Med 2015, 15:371. doi: 10.​1186/​s12906-015-0902-2.
19.
go back to reference Dunnett CW. New tables for multiple comparisons with control. Biometrics. 1964;20:482–91.CrossRef Dunnett CW. New tables for multiple comparisons with control. Biometrics. 1964;20:482–91.CrossRef
24.
27.
go back to reference Kumar VS, Rajmane AR, Adil M, Kandhare AD, Ghosh P, Bodhankar SL. Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats. J Biomed Res. 2014;28:132–45. doi:10.7555/JBR.27.20120082.PubMed Kumar VS, Rajmane AR, Adil M, Kandhare AD, Ghosh P, Bodhankar SL. Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats. J Biomed Res. 2014;28:132–45. doi:10.​7555/​JBR.​27.​20120082.PubMed
29.
go back to reference Saralamma VV, Nagappan A, Hong GE, Lee HJ, Yumnam S, Raha S, Heo JD, Lee SJ, Lee WS, Kim EH, Kim GS. Poncirin induces apoptosis in AGS human gastric cancer cells through extrinsic apoptotic pathway by up-regulation of Fas ligand. Int J Mol Sci. 2015;16:22676–91. doi:10.3390/ijms160922676.CrossRefPubMed Saralamma VV, Nagappan A, Hong GE, Lee HJ, Yumnam S, Raha S, Heo JD, Lee SJ, Lee WS, Kim EH, Kim GS. Poncirin induces apoptosis in AGS human gastric cancer cells through extrinsic apoptotic pathway by up-regulation of Fas ligand. Int J Mol Sci. 2015;16:22676–91. doi:10.​3390/​ijms160922676.CrossRefPubMed
31.
go back to reference Guo W, Sun J, Jiang L, Duan L, Huo M, Chen N, Zhong W, Wassy L, Yang Z, Feng H. Imperatorin attenuates LPS-induced inflammation by suppressing NF-κB and MAPKs activation in RAW 264.7 macrophages. Inflammation. 2012;35:1764–72. doi:10.1007/s10753-012-9495-9.CrossRefPubMed Guo W, Sun J, Jiang L, Duan L, Huo M, Chen N, Zhong W, Wassy L, Yang Z, Feng H. Imperatorin attenuates LPS-induced inflammation by suppressing NF-κB and MAPKs activation in RAW 264.7 macrophages. Inflammation. 2012;35:1764–72. doi:10.​1007/​s10753-012-9495-9.CrossRefPubMed
Metadata
Title
Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats
Authors
Woo-Young Jeon
Ohn Soon Kim
Chang-Seob Seo
Seong Eun Jin
Jung-Ae Kim
Hyeun-Kyoo Shin
Yong-ung Kim
Mee-Young Lee
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1877-y

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue